Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Drake

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Thorax|March 1, 1997
Pulmonary artery occlusion by tuberculous mediastinal lymphadenopathyW M Drake, S L Elkin, A al-Kutoubi, et al.
QJM : Monthly Journal of the Association of Physicians|February 4, 2010
Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowelM R Druce, N Bharwani, S A Akker, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed mealC Parkinson, W M Drake, M E Roberts, et al.
Endocrinology|January 14, 1999
Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesisW M Drake, A Ajayi, S R Lowe, et al.
Clinical Endocrinology|April 10, 2002
Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegalyC Parkinson, W M Drake, G Wieringa, et al.
European Journal of Endocrinology|October 3, 2001
Successful treatment of resistant acromegaly with a growth hormone receptor antagonistW M Drake, C Parkinson, S A Akker, et al.
European Journal of Endocrinology|March 15, 2005
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomantW M Drake, R A Loureiro, C Parkinson, et al.
European Journal of Endocrinology|June 19, 2014
Denosumab for management of refractory hypercalcaemia in recurrent parathyroid carcinomaK Nadarasa, A Theodoraki, T R Kurzawinski, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 1998
Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisoloneW M Drake, J P Monson, P J Trainer, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitisW M Drake, L A Perry, C J Hinds, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Thorax|March 1, 1997
Pulmonary artery occlusion by tuberculous mediastinal lymphadenopathyW M Drake, S L Elkin, A al-Kutoubi, et al.
QJM : Monthly Journal of the Association of Physicians|February 4, 2010
Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowelM R Druce, N Bharwani, S A Akker, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed mealC Parkinson, W M Drake, M E Roberts, et al.
Endocrinology|January 14, 1999
Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesisW M Drake, A Ajayi, S R Lowe, et al.
Clinical Endocrinology|April 10, 2002
Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegalyC Parkinson, W M Drake, G Wieringa, et al.
European Journal of Endocrinology|October 3, 2001
Successful treatment of resistant acromegaly with a growth hormone receptor antagonistW M Drake, C Parkinson, S A Akker, et al.
European Journal of Endocrinology|March 15, 2005
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomantW M Drake, R A Loureiro, C Parkinson, et al.
European Journal of Endocrinology|June 19, 2014
Denosumab for management of refractory hypercalcaemia in recurrent parathyroid carcinomaK Nadarasa, A Theodoraki, T R Kurzawinski, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 1998
Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisoloneW M Drake, J P Monson, P J Trainer, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitisW M Drake, L A Perry, C J Hinds, et al.
Pageof 9